EcoDrugPlus

Nad(P)h Dehydrogenase, Quinone 1

Ensembl ID : ENSACLG00000001590
Gene Symbol: NQO1
1 Cross references
185 Possible Orthologues:

Nad(P)h Dehydrogenase, Quinone 1

Ensembl ID : ENSACLG00000001581
Gene Symbol: NQO1
1 Cross references
185 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSACLG00000012053
Gene Symbol: NPC1L1
4 Cross references
190 Possible Orthologues:

P-Selectin-Like

Ensembl ID : ENSACLG00000024863
Gene Symbol: LOC113015921
3 Cross references
170 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSACLG00000018368
Gene Symbol: LOC113024806
3 Cross references
200 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSACLG00000013925
Gene Symbol: LOC113029489
3 Cross references
194 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSACLG00000014620
Gene Symbol: LOC113036280
3 Cross references
182 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSACLG00000008866
Gene Symbol: PTK6B
1 Cross references
160 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSACLG00000004124
Gene Symbol: PIM3
3 Cross references
196 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSACLG00000004632
Gene Symbol: LOC113030100
3 Cross references
182 Possible Orthologues:

Rac-Gamma Serine/threonine-Protein Kinase

Ensembl ID : ENSACLG00000022987
Gene Symbol: LOC113034924
3 Cross references
203 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSACLG00000016625
Gene Symbol: ROCK1
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).